Depomed, a specialty pharmaceutical company, has hired August (Augie) Moretti as senior vice president (SVP) and chief financial officer (CFO). Moretti is an experienced senior financial executive and expert in securities law whose involvement in the biopharmaceutical industry spans more than three decades.
Moretti joins from Alexza Pharmaceuticals, where he served as CFO, SVP, general counsel and secretary. Previously, he served as CFO and general counsel of Alavita (formerly Surromed). Moretti has extensive experience with both private and public companies on issues relating to disclosure and public reporting, and public and private financings. Earlier in his career, he was a member of Heller Ehrman White & McAuliffe, where he represented a number of life science companies. Moretti holds a BA degree in Economics from Princeton University and a JD from Harvard Law School.
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more